Guardant Health Files 8-K
Ticker: GH · Form: 8-K · Filed: Sep 24, 2025 · CIK: 1576280
| Field | Detail |
|---|---|
| Company | Guardant Health, Inc. (GH) |
| Form Type | 8-K |
| Filed Date | Sep 24, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.00001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulation-fd, disclosure
Related Tickers: GDNT
TL;DR
GDNT filed a routine 8-K on 9/24/25, no major news.
AI Summary
Guardant Health, Inc. filed an 8-K on September 24, 2025, to report information under Regulation FD. The filing does not contain specific financial transactions or material events beyond the standard disclosure requirements for this form.
Why It Matters
This filing indicates Guardant Health is making a regulatory disclosure, which is a standard procedural step for public companies.
Risk Assessment
Risk Level: low — The filing is a standard procedural disclosure under Regulation FD and does not contain information about significant financial events or strategic changes.
Key Players & Entities
- Guardant Health, Inc. (company) — Registrant
- September 24, 2025 (date) — Date of report
FAQ
What is the purpose of this 8-K filing?
This 8-K filing is made pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 and is intended to report information under Regulation FD.
What is the exact name of the registrant?
The exact name of the registrant is Guardant Health, Inc.
In which state was Guardant Health, Inc. incorporated?
Guardant Health, Inc. was incorporated in Delaware.
What is the principal executive office address for Guardant Health, Inc.?
The address of the principal executive offices is 3100 Hanover Street, Palo Alto, California 94304.
What is the registrant's telephone number?
The registrant's telephone number is 855-698-8887.
Filing Stats: 513 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2025-09-24 07:50:17
Key Financial Figures
- $0.00001 — nge on which registered Common Stock, $0.00001 par value per share GH The Nasdaq Glo
Filing Documents
- gh-20250924.htm (8-K) — 27KB
- 0001576280-25-000269.txt ( ) — 140KB
- gh-20250924.xsd (EX-101.SCH) — 2KB
- gh-20250924_lab.xml (EX-101.LAB) — 21KB
- gh-20250924_pre.xml (EX-101.PRE) — 12KB
- gh-20250924_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure . Guardant Health, Inc. (the "Company") will host an Investor Day on September 24, 2025 beginning at 9:00 a.m. Eastern time in New York City. The presentation will include remarks from Helmy Eltoukhy and AmirAli Talasaz, co-Chief Executive Officers, and other members of the executive management team, to highlight the Company's operations and to provide updates to the Company's key strategic priorities and financial outlook. All interested parties may access the live and archived webcast of the presentation on the "Investors" section of the Company's website at: www.guardanthealth.com. The information in this Current Report on Form 8-K is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GUARDANT HEALTH, INC. Date: September 24, 2025 By: /s/ John G. Saia John G. Saia Chief Legal Officer and Corporate Secretary